Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Delayed Nasdaq  -  04:00 2022-12-08 pm EST
46.51 USD   +1.62%
11/22LeMaitre to Present at Upcoming Investor Conferences
AQ
11/16LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/08LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/02/2022 12/05/2022 12/06/2022 12/07/2022 12/08/2022 Date
47.17(c) 46.01(c) 45.46(c) 45.77(c) 46.51(c) Last
48 795 68 963 39 529 42 673 63 474 Volume
-0.53% -2.46% -1.20% +0.68% +1.62% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 162 M - -
Net income 2022 20,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 50,0x
Yield 2022 1,08%
Sales 2023 173 M - -
Net income 2023 27,2 M - -
Net Debt 2023 - - -
P/E ratio 2023 38,4x
Yield 2023 1,08%
Capitalization 1 023 M 1 023 M -
Capi. / Sales 2022 6,32x
Capi. / Sales 2023 5,91x
Nbr of Employees 469
Free-Float 82,5%
More Financials
Company
LeMaitre Vascular, Inc. is a provider of medical devices and human tissue cryopreservation services, which are used in the treatment of peripheral vascular disease, end-stage renal disease and to a lesser extent cardiovascular disease. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general... 
Sector
Advanced Medical Equipment & Technology
Calendar
12/08 | 01:15pmPresentation
More about the company
Ratings of LeMaitre Vascular, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about LEMAITRE VASCULAR, INC.
11/22LeMaitre to Present at Upcoming Investor Conferences
AQ
11/16LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/08LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and ..
AQ
11/02LeMaitre to Present at Upcoming Investor Conferences
AQ
10/31North American Morning Briefing: Futures Pull -3-
DJ
10/28Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
10/27Lemaitre : Q3 Earnings Snapshot
AQ
10/27Transcript : LeMaitre Vascular, Inc., Q3 2022 Earnings Call, Oct 27, 2022
CI
10/27LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
10/27Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q3 Revenue $39M
MT
10/27LeMaitre Q3 2022 Financial Results
AQ
10/27LeMaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year..
CI
10/27LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on December 1, 2022
CI
10/17LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
AQ
09/23Lemaitre Vascular Inc : Change in Directors or Principal Officers (form 8-K)
AQ
More news
News in other languages on LEMAITRE VASCULAR, INC.
10/27LeMaitre Vascular, Inc. annonce ses résultats financiers pour le troisième trimestre et..
10/27LeMaitre Vascular, Inc. fournit des prévisions de résultats pour le quatrième trimestre..
10/27LeMaitre Vascular, Inc. approuve un dividende trimestriel, payable le 1er décembre 2022
09/23Lemaitre Vascular, Inc. nomme Martha Shadan au poste de directrice
07/29LeMaitre Vascular affiche un bénéfice ajusté plus faible au 2ème trimestre, une hausse ..
More news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
More recommendations
ETFs positioned on LEMAITRE VASCULAR, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
ProShares Russell 2000 Dividend Growers ETF - USD1.12%0.88%United_States
Janus Small Cap Growth Alpha ETF - USD0.99%-3.17%United_States
Invesco S&P SmallCap Health Care ETF - USD0.97%-2.89%United_States
Hartford Multifactor Small Cap ETF - USD0.51%-3.10%-North America
LEGG MASON SMALL-CAP QUALITY Value ETF - Di...0.32%-2.71%United_States
More ETFs positioned on LEMAITRE VASCULAR, INC.
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 46,51 $
Average target price 58,83 $
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts Chief Financial Officer
Joseph P. Pellegrino Chief Financial Officer, Secretary & Director
Jonathan W. Ngau Director-Information Technology
Ryan H. Connelly Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
LEMAITRE VASCULAR, INC.-8.88%1 023
THERMO FISHER SCIENTIFIC-14.88%219 934
DANAHER CORPORATION-18.47%195 269
INTUITIVE SURGICAL, INC.-24.29%94 693
BOSTON SCIENTIFIC CORPORATION7.42%65 356
SIEMENS HEALTHINEERS AG-24.89%57 925